Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based on the American College of Obstetricians and Gynecologists Committee on Genetics recommendation that cell-free fetal DNA testing be used in high-risk women. The firm also doubles its price target to $8 from $4.
Shares of Sequenom (SQNM +7%) jump today after Stephens upgraded the stock to Overweight based...
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs